Related Experiment Video
Updated: Apr 20, 2026
Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
Published on: October 20, 2021
Identification and retrospective validation of T-cell epitopes in the hepatitis C virus genotype 4 proteome: an
Karim M Abdel-Hady1, Andres H Gutierrez, Frances Terry
1a Department of Chemistry; School of Sciences and Engineering; The American University in Cairo; New Cairo, Egypt.
Insights
Hepatitis C virus (HCV) genotype 4 research identified new T-cell epitopes for vaccine development. This study focused on genotype 4, prevalent in the Middle East and Africa, offering potential for a targeted HCV vaccine.
Area of Science:
- Immunology
- Virology
- Vaccinology
Background:
- Hepatitis C virus (HCV) infection affects over 150 million people globally, presenting a significant healthcare burden.
- Current therapies for HCV are costly, have side effects, and variable efficacy.
- HCV vaccine development faces challenges due to viral immune evasion, with limited focus on genotype 4.
Purpose of the Study:
- To identify conserved and immunogenic T-cell epitopes from HCV genotype 4 for vaccine development.
- To establish a rapid and cost-effective method for validating potential vaccine targets.
- To address the research gap concerning HCV genotype 4, prevalent in specific global regions.
Main Methods:
- In silico identification of T-cell epitopes from the HCV genotype 4 proteome using the iVAX immunoinformatics toolkit.
- Retrospective validation of predicted epitopes using empirical data from the Immune Epitope Database (IEDB).
- Analysis of both HLA class I and HLA class II epitopes for immunogenicity and conservation.
Main Results:
- Identification of 90 HLA class I T-cell epitopes, including 20 novel ones. Binding predictions for 19 epitopes were retrospectively validated.
- Identification of 14 HLA class II T-cell epitopes, with 8 showing validated binding predictions.
- Insufficient empirical data was available to validate binding predictions for 51 HLA class I epitopes.
Conclusions:
- The study identified potential T-cell epitope targets for an HCV genotype 4-specific vaccine.
- The findings highlight the need for further research into the efficacy of these epitopes in relevant populations.
- This epitope-driven approach offers a promising strategy for developing a more targeted and effective HCV vaccine.
Abstract:
With over 150 million people chronically infected worldwide and millions more infected annually, hepatitis C continues to pose a burden on the global healthcare system. The standard therapy of hepatitis C remains expensive, with severe associated side effects and inconsistent cure rates. Vaccine development against the hepatitis C virus has been hampered by practical and biological challenges posed by viral evasion mechanisms. Despite these challenges, HCV vaccine research has presented a number of candidate vaccines that progressed to phase II trials. However, those efforts focused mainly on HCV genotypes 1 and 2 as vaccine targets and barely enough attention was given to genotype 4, the variant most prevalent in the Middle East and central Africa. We describe herein the in silico identification of highly conserved and immunogenic T-cell epitopes from the HCV genotype 4 proteome, using the iVAX immunoinformatics toolkit, as targets for an epitope-driven vaccine. We also describe a fast and inexpensive approach for results validation using the empirical data on the Immune Epitope Database (IEDB) as a reference. Our analysis identified 90 HLA class I epitopes of which 20 were found to be novel and 19 more had their binding predictions retrospectively validated; empirical data for the remaining 51 epitopes was insufficient to validate their binding predictions. Our analysis also identified 14 HLA class II epitopes, of which 8 had most of their binding predictions validated. Further investigation is required regarding the efficacy of the identified epitopes as vaccine targets in populations where HCV genotype 4 is most prevalent.
